APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomedical Materials

Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.

Selected research

Market Analysis & Forecast

Global Biomedical Materials Market Analysis and Forecast 2026-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchBiomedical Materials Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomedical Materials Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biomedical Materials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomedical Materials Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomedical Materials Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.

Global Biomedical Materials key players include Johnson & Johnson, ZimmerBiomet, Medtronic, Abbott Laboratories, etc. Global top four manufacturers hold a share about 30%.

North America is the largest market, with a share over 55%, followed by Europe, and Rest of Asia, both have a share over 25 percent.

Read the full market overview

In terms of product, Plastic Surgery is the largest segment, with a share over 20%. And in terms of application, the largest application is Treatment, followed by Health and Beauty.

Report Includes

This report presents an overview of global market for Biomedical Materials, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biomedical Materials, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomedical Materials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biomedical Materials revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomedical Materials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomedical Materials revenue, projected growth trends, production technology, application and end-user industry.

Biomedical Materials Segment by Company

Johnson & Johnson

ZimmerBiomet

Medtronic

Abbott Laboratories

Stryker

Boston Scientific

Smith+Nephew

B-Braun

Straumann

Danaher Corporation

Dentsply Sirona

Cook Medical

Terumo

MicroPort

Lepu Medical

Biomedical Materials Segment by Type

Orthopaedic

Cardiac Surgery

Neurosurgery

Plastic Surgery

Other

Biomedical Materials Segment by Application

Treatment

Health and Beauty

Biomedical Materials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Materials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biomedical Materials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biomedical Materials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomedical Materials revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomedical Materials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Orthopaedic Major Player Table 3. Cardiac Surgery Major Player Table 4. Neurosurgery Major Player Table 5. Plastic Surgery Major Player Table 6. Other Major Player Table 7. Global Biomedical Materials Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Treatment Major Player Table 9. Health and Beauty Major Player Table 10. Biomedical Materials Industry Trends Table 11. Biomedical Materials Industry Drivers Table 12. Biomedical Materials Industry Opportunities and Challenges Table 13. Biomedical Materials Industry Restraints Table 14. Global Biomedical Materials Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Biomedical Materials Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Biomedical Materials Market Share by Region (2021-2026) Table 17. Global Biomedical Materials Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Biomedical Materials Market Share by Region (2027-2032) Table 19. Global Biomedical Materials Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Biomedical Materials Revenue Market Share by Players (2021-2026) Table 21. Global Biomedical Materials Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Biomedical Materials Key Players Headquarters & Area Served Table 23. Global Biomedical Materials Players, Product Type & Application Table 24. Global Biomedical Materials Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Biomedical Materials by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Biomedical Materials Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biomedical Materials Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Biomedical Materials Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Biomedical Materials Revenue Market Share by Type (2021-2026) Table 31. Global Biomedical Materials Revenue Market Share by Type (2027-2032) Table 32. Global Biomedical Materials Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Biomedical Materials Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Biomedical Materials Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Biomedical Materials Revenue Market Share by Application (2021-2026) Table 36. Global Biomedical Materials Revenue Market Share by Application (2027-2032) Table 37. Johnson & Johnson Company Information Table 38. Johnson & Johnson Business Overview Table 39. Johnson & Johnson Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Johnson & Johnson Biomedical Materials Product Portfolio Table 41. Johnson & Johnson Recent Development Table 42. ZimmerBiomet Company Information Table 43. ZimmerBiomet Business Overview Table 44. ZimmerBiomet Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. ZimmerBiomet Biomedical Materials Product Portfolio Table 46. ZimmerBiomet Recent Development Table 47. Medtronic Company Information Table 48. Medtronic Business Overview Table 49. Medtronic Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Medtronic Biomedical Materials Product Portfolio Table 51. Medtronic Recent Development Table 52. Abbott Laboratories Company Information Table 53. Abbott Laboratories Business Overview Table 54. Abbott Laboratories Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Abbott Laboratories Biomedical Materials Product Portfolio Table 56. Abbott Laboratories Recent Development Table 57. Stryker Company Information Table 58. Stryker Business Overview Table 59. Stryker Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Stryker Biomedical Materials Product Portfolio Table 61. Stryker Recent Development Table 62. Boston Scientific Company Information Table 63. Boston Scientific Business Overview Table 64. Boston Scientific Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Boston Scientific Biomedical Materials Product Portfolio Table 66. Boston Scientific Recent Development Table 67. Smith+Nephew Company Information Table 68. Smith+Nephew Business Overview Table 69. Smith+Nephew Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Smith+Nephew Biomedical Materials Product Portfolio Table 71. Smith+Nephew Recent Development Table 72. B-Braun Company Information Table 73. B-Braun Business Overview Table 74. B-Braun Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. B-Braun Biomedical Materials Product Portfolio Table 76. B-Braun Recent Development Table 77. Straumann Company Information Table 78. Straumann Business Overview Table 79. Straumann Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Straumann Biomedical Materials Product Portfolio Table 81. Straumann Recent Development Table 82. Danaher Corporation Company Information Table 83. Danaher Corporation Business Overview Table 84. Danaher Corporation Biomedical Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Danaher Corporation Biomedical Materials Product Portfolio Table 86. Danaher Corporation Recent Development Table 87. Dentsply Sirona Company Information Table 88. Dentsply Sirona Business Overview Table 89. Dentsply Sirona Biomedical Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Dentsply Sirona Biomedical Materials Product Portfolio Table 91. Dentsply Sirona Recent Development Table 92. Cook Medical Company Information Table 93. Cook Medical Business Overview Table 94. Cook Medical Biomedical Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Cook Medical Biomedical Materials Product Portfolio Table 96. Cook Medical Recent Development Table 97. Terumo Company Information Table 98. Terumo Business Overview Table 99. Terumo Biomedical Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Terumo Biomedical Materials Product Portfolio Table 101. Terumo Recent Development Table 102. MicroPort Company Information Table 103. MicroPort Business Overview Table 104. MicroPort Biomedical Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. MicroPort Biomedical Materials Product Portfolio Table 106. MicroPort Recent Development Table 107. Lepu Medical Company Information Table 108. Lepu Medical Business Overview Table 109. Lepu Medical Biomedical Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Lepu Medical Biomedical Materials Product Portfolio Table 111. Lepu Medical Recent Development Table 112. North America Biomedical Materials Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Biomedical Materials Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Biomedical Materials Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Biomedical Materials Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Biomedical Materials Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Biomedical Materials Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Biomedical Materials Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Biomedical Materials Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Biomedical Materials Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Biomedical Materials Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Biomedical Materials Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Biomedical Materials Revenue by Country (US$ Million) & (2027-2032) Table 126. China Biomedical Materials Revenue by Type (2021-2026) & (US$ Million) Table 127. China Biomedical Materials Revenue by Type (2027-2032) & (US$ Million) Table 128. China Biomedical Materials Revenue by Application (2021-2026) & (US$ Million) Table 129. China Biomedical Materials Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Biomedical Materials Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Biomedical Materials Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Biomedical Materials Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Biomedical Materials Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Biomedical Materials Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Biomedical Materials Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Biomedical Materials Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Biomedical Materials Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Biomedical Materials Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Biomedical Materials Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Biomedical Materials Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Biomedical Materials Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Biomedical Materials Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Biomedical Materials Image Figure 2. Global Biomedical Materials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical Materials Market Size Share 2021 VS 2025 VS 2032 Figure 4. Orthopaedic Image Figure 5. Cardiac Surgery Image Figure 6. Neurosurgery Image Figure 7. Plastic Surgery Image Figure 8. Other Image Figure 9. Global Biomedical Materials Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Biomedical Materials Market Size Share 2021 VS 2025 VS 2032 Figure 11. Treatment Image Figure 12. Health and Beauty Image Figure 13. Global Biomedical Materials Market Size (US$ Million) & (2021-2032) Figure 14. Global Biomedical Materials Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Biomedical Materials Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Biomedical Materials Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Biomedical Materials Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biomedical Materials Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Biomedical Materials Revenue Market Share by Type (2021-2032) Figure 21. Global Biomedical Materials Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biomedical Materials Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Biomedical Materials Revenue Market Share by Application (2021-2032) Figure 24. North America Biomedical Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Biomedical Materials Revenue Share by Type (2021-2032) Figure 26. North America Biomedical Materials Revenue Share by Application (2021-2032) Figure 27. North America Biomedical Materials Revenue Share by Country (2021-2032) Figure 28. United States Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Biomedical Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Biomedical Materials Revenue Share by Type (2021-2032) Figure 33. Europe Biomedical Materials Revenue Share by Application (2021-2032) Figure 34. Europe Biomedical Materials Revenue Share by Country (2021-2032) Figure 35. Germany Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Biomedical Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Biomedical Materials Revenue Share by Type (2021-2032) Figure 45. China Biomedical Materials Revenue Share by Application (2021-2032) Figure 46. Asia Biomedical Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Biomedical Materials Revenue Share by Type (2021-2032) Figure 48. Asia Biomedical Materials Revenue Share by Application (2021-2032) Figure 49. Asia Biomedical Materials Revenue Share by Region (2021-2032) Figure 50. Japan Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Biomedical Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Biomedical Materials Revenue Share by Type (2021-2032) Figure 58. SAMEA Biomedical Materials Revenue Share by Application (2021-2032) Figure 59. SAMEA Biomedical Materials Revenue Share by Country (2021-2032) Figure 60. Brazil Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Biomedical Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Orthopaedic
  • Cardiac Surgery
  • Neurosurgery
  • Plastic Surgery
  • Other
Applications
  • Treatment
  • Health and Beauty
Companies covered
  • Johnson & Johnson
  • ZimmerBiomet
  • Medtronic
  • Abbott Laboratories
  • Stryker
  • Boston Scientific
  • Smith+Nephew
  • B-Braun
  • Straumann
  • Danaher Corporation
  • Dentsply Sirona
  • Cook Medical
  • Terumo
  • MicroPort
  • Lepu Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biomedical Materials Market by Type
  3. 1.2.1 Global Biomedical Materials Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Orthopaedic
  5. 1.2.3 Cardiac Surgery
  6. 1.2.4 Neurosurgery
  7. 1.2.5 Plastic Surgery
  8. 1.2.6 Other
  9. 1.3 Biomedical Materials Market by Application
  10. 1.3.1 Global Biomedical Materials Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Treatment
  12. 1.3.3 Health and Beauty
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Biomedical Materials Market Dynamics
  1. 2.1 Biomedical Materials Industry Trends
  2. 2.2 Biomedical Materials Industry Drivers
  3. 2.3 Biomedical Materials Industry Opportunities and Challenges
  4. 2.4 Biomedical Materials Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biomedical Materials Market Perspective (2021-2032)
  2. 3.2 Global Biomedical Materials Growth Trends by Region
  3. 3.2.1 Global Biomedical Materials Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biomedical Materials Market Size by Region (2021-2026)
  5. 3.2.3 Global Biomedical Materials Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biomedical Materials Revenue by Players
  2. 4.1.1 Global Biomedical Materials Revenue by Players (2021-2026)
  3. 4.1.2 Global Biomedical Materials Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biomedical Materials Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biomedical Materials Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biomedical Materials Key Players Headquarters & Area Served
  7. 4.4 Global Biomedical Materials Players, Product Type & Application
  8. 4.5 Global Biomedical Materials Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biomedical Materials Market CR5 and HHI
  11. 4.6.3 2025 Biomedical Materials Tier 1, Tier 2, and Tier 3
5 Biomedical Materials Market Size by Type
  1. 5.1 Global Biomedical Materials Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomedical Materials Revenue by Type (2021-2032)
  3. 5.3 Global Biomedical Materials Revenue Market Share by Type (2021-2032)
6 Biomedical Materials Market Size by Application
  1. 6.1 Global Biomedical Materials Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biomedical Materials Revenue by Application (2021-2032)
  3. 6.3 Global Biomedical Materials Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Biomedical Materials Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Biomedical Materials Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 ZimmerBiomet
  8. 7.2.1 ZimmerBiomet Company Information
  9. 7.2.2 ZimmerBiomet Business Overview
  10. 7.2.3 ZimmerBiomet Biomedical Materials Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ZimmerBiomet Biomedical Materials Product Portfolio
  12. 7.2.5 ZimmerBiomet Recent Developments
  13. 7.3 Medtronic
  14. 7.3.1 Medtronic Company Information
  15. 7.3.2 Medtronic Business Overview
  16. 7.3.3 Medtronic Biomedical Materials Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Medtronic Biomedical Materials Product Portfolio
  18. 7.3.5 Medtronic Recent Developments
  19. 7.4 Abbott Laboratories
  20. 7.4.1 Abbott Laboratories Company Information
  21. 7.4.2 Abbott Laboratories Business Overview
  22. 7.4.3 Abbott Laboratories Biomedical Materials Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Laboratories Biomedical Materials Product Portfolio
  24. 7.4.5 Abbott Laboratories Recent Developments
  25. 7.5 Stryker
  26. 7.5.1 Stryker Company Information
  27. 7.5.2 Stryker Business Overview
  28. 7.5.3 Stryker Biomedical Materials Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Stryker Biomedical Materials Product Portfolio
  30. 7.5.5 Stryker Recent Developments
  31. 7.6 Boston Scientific
  32. 7.6.1 Boston Scientific Company Information
  33. 7.6.2 Boston Scientific Business Overview
  34. 7.6.3 Boston Scientific Biomedical Materials Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Boston Scientific Biomedical Materials Product Portfolio
  36. 7.6.5 Boston Scientific Recent Developments
  37. 7.7 Smith+Nephew
  38. 7.7.1 Smith+Nephew Company Information
  39. 7.7.2 Smith+Nephew Business Overview
  40. 7.7.3 Smith+Nephew Biomedical Materials Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Smith+Nephew Biomedical Materials Product Portfolio
  42. 7.7.5 Smith+Nephew Recent Developments
  43. 7.8 B-Braun
  44. 7.8.1 B-Braun Company Information
  45. 7.8.2 B-Braun Business Overview
  46. 7.8.3 B-Braun Biomedical Materials Revenue and Gross Margin (2021-2026)
  47. 7.8.4 B-Braun Biomedical Materials Product Portfolio
  48. 7.8.5 B-Braun Recent Developments
  49. 7.9 Straumann
  50. 7.9.1 Straumann Company Information
  51. 7.9.2 Straumann Business Overview
  52. 7.9.3 Straumann Biomedical Materials Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Straumann Biomedical Materials Product Portfolio
  54. 7.9.5 Straumann Recent Developments
  55. 7.10 Danaher Corporation
  56. 7.10.1 Danaher Corporation Company Information
  57. 7.10.2 Danaher Corporation Business Overview
  58. 7.10.3 Danaher Corporation Biomedical Materials Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Danaher Corporation Biomedical Materials Product Portfolio
  60. 7.10.5 Danaher Corporation Recent Developments
  61. 7.11 Dentsply Sirona
  62. 7.11.1 Dentsply Sirona Company Information
  63. 7.11.2 Dentsply Sirona Business Overview
  64. 7.11.3 Dentsply Sirona Biomedical Materials Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Dentsply Sirona Biomedical Materials Product Portfolio
  66. 7.11.5 Dentsply Sirona Recent Developments
  67. 7.12 Cook Medical
  68. 7.12.1 Cook Medical Company Information
  69. 7.12.2 Cook Medical Business Overview
  70. 7.12.3 Cook Medical Biomedical Materials Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Cook Medical Biomedical Materials Product Portfolio
  72. 7.12.5 Cook Medical Recent Developments
  73. 7.13 Terumo
  74. 7.13.1 Terumo Company Information
  75. 7.13.2 Terumo Business Overview
  76. 7.13.3 Terumo Biomedical Materials Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Terumo Biomedical Materials Product Portfolio
  78. 7.13.5 Terumo Recent Developments
  79. 7.14 MicroPort
  80. 7.14.1 MicroPort Company Information
  81. 7.14.2 MicroPort Business Overview
  82. 7.14.3 MicroPort Biomedical Materials Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MicroPort Biomedical Materials Product Portfolio
  84. 7.14.5 MicroPort Recent Developments
  85. 7.15 Lepu Medical
  86. 7.15.1 Lepu Medical Company Information
  87. 7.15.2 Lepu Medical Business Overview
  88. 7.15.3 Lepu Medical Biomedical Materials Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Lepu Medical Biomedical Materials Product Portfolio
  90. 7.15.5 Lepu Medical Recent Developments
8 North America
  1. 8.1 North America Biomedical Materials Revenue (2021-2032)
  2. 8.2 North America Biomedical Materials Revenue by Type (2021-2032)
  3. 8.2.1 North America Biomedical Materials Revenue by Type (2021-2026)
  4. 8.2.2 North America Biomedical Materials Revenue by Type (2027-2032)
  5. 8.3 North America Biomedical Materials Revenue Share by Type (2021-2032)
  6. 8.4 North America Biomedical Materials Revenue by Application (2021-2032)
  7. 8.4.1 North America Biomedical Materials Revenue by Application (2021-2026)
  8. 8.4.2 North America Biomedical Materials Revenue by Application (2027-2032)
  9. 8.5 North America Biomedical Materials Revenue Share by Application (2021-2032)
  10. 8.6 North America Biomedical Materials Revenue by Country
  11. 8.6.1 North America Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biomedical Materials Revenue by Country (2021-2026)
  13. 8.6.3 North America Biomedical Materials Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biomedical Materials Revenue (2021-2032)
  2. 9.2 Europe Biomedical Materials Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biomedical Materials Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biomedical Materials Revenue by Type (2027-2032)
  5. 9.3 Europe Biomedical Materials Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biomedical Materials Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biomedical Materials Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biomedical Materials Revenue by Application (2027-2032)
  9. 9.5 Europe Biomedical Materials Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biomedical Materials Revenue by Country
  11. 9.6.1 Europe Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biomedical Materials Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biomedical Materials Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biomedical Materials Revenue (2021-2032)
  2. 10.2 China Biomedical Materials Revenue by Type (2021-2032)
  3. 10.2.1 China Biomedical Materials Revenue by Type (2021-2026)
  4. 10.2.2 China Biomedical Materials Revenue by Type (2027-2032)
  5. 10.3 China Biomedical Materials Revenue Share by Type (2021-2032)
  6. 10.4 China Biomedical Materials Revenue by Application (2021-2032)
  7. 10.4.1 China Biomedical Materials Revenue by Application (2021-2026)
  8. 10.4.2 China Biomedical Materials Revenue by Application (2027-2032)
  9. 10.5 China Biomedical Materials Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biomedical Materials Revenue (2021-2032)
  2. 11.2 Asia Biomedical Materials Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biomedical Materials Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biomedical Materials Revenue by Type (2027-2032)
  5. 11.3 Asia Biomedical Materials Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biomedical Materials Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biomedical Materials Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biomedical Materials Revenue by Application (2027-2032)
  9. 11.5 Asia Biomedical Materials Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biomedical Materials Revenue by Country
  11. 11.6.1 Asia Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biomedical Materials Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biomedical Materials Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biomedical Materials Revenue (2021-2032)
  2. 12.2 SAMEA Biomedical Materials Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biomedical Materials Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biomedical Materials Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biomedical Materials Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biomedical Materials Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biomedical Materials Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biomedical Materials Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biomedical Materials Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biomedical Materials Revenue by Country
  11. 12.6.1 SAMEA Biomedical Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biomedical Materials Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biomedical Materials Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst